Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Delivery of α-Particles By a Human-Rat Chimeric CD82 Monoclonal Antibody Potently Inhibits the Proliferation of CD82-Expressing Acute Myeloid Leukemia Cells in a Murine Xenograft Model

Takayuki Ikezoe, Taro Tachibana, Chiaki Hata, Cai-Xia Wang, Daisuke Koyama, Noboru Oriuchi, Ken-ichi Nishijima, Naoyuki Ukon, Saki Shimoyama, Taiki Joho, Kohshin Washiyama, Kazuhiro Takahashi, Songji Zhao

Blood (2023) 142 (Supplement 1): 2794.

https://doi.org/10.1182/blood-2023-174676

Published: 2023

Journal Articles

Application of Comprehensive Nursing Program Based on Evidence-Based Concept in Patients with HIV-Related Lymphoma

Jing Lv, Cuiting Jiang, Xia Wang, Yuhong Deng, Qin Luo, Tingting Liu, Yao Liu

Blood (2023) 142 (Supplement 1): 7265.

https://doi.org/10.1182/blood-2023-182681

Published: 2023

Journal Articles

Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China

Baiyan Wang, MD PhD, Jie Liu, MD, Wan-Hong Zhao, MD PhD, Yin-Xia Chen, MD, Xing-Mei Cao, MD, Yun Yang, MD, Yi-Lin Zhang, MD, Fang-Xia Wang, MD PhD, Peng-Yu Zhang, MD PhD, Bo Lei, MD, Liu-Fang Gu, MD PhD, Jian-Li Wang, MD PhD, Frank Xiao-Hu Fan, MD PhD, Wang-Gang Zhang, MD PhD, Ai-Li He, MD PhD

Blood (2020) 136 (Supplement 1): 6.

https://doi.org/10.1182/blood-2020-140243

Published: 2020

Journal Articles

Long-Term Follow-up of a Phase 1, First-in-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (BCMA), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Blood (2019) 134 (Supplement_1): 579.

https://doi.org/10.1182/blood-2019-124953

Published: 2019

Journal Articles

Using Circ-ANAPC7 As a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia

Ying Shen, MD, Yachun Jia, Ru Zhang, MD, Hongli Chen, Yuandong Feng, MD, Fang-Xia Wang, MD PhD, Wanhong Zhao, MD, Jianli Wang, MD, Aili He, Yun Yang, MD, Yan Xu

Blood (2019) 134 (Supplement_1): 5179.

https://doi.org/10.1182/blood-2019-128179

Published: 2019

Journal Articles

Silencing Long Non-Coding RNA ST3GAL6-AS1 Inhibits Adhesion and Migration of Myeloma Cells in Vitro

Ying Shen, MD, Yuandong Feng, MD, Hongli Chen, Yachun Jia, Yue Peng, Ru Zhang, MD, Yun Yang, MD, Jian-Li Wang, MD PhD, Ju Bai, PhD, Fang-Xia Wang, MD PhD, Yan Xu, Jinsong Hu, PhD, Aili He, MD

Blood (2018) 132 (Supplement 1): 4470.

https://doi.org/10.1182/blood-2018-99-114660

Published: 2018

Journal Articles

Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

Blood (2018) 132 (Supplement 1): 955.

https://doi.org/10.1182/blood-2018-99-110548

Published: 2018

Journal Articles

A 3-LncRNA Risk Scoring System for Prognosis of Adult Acute Myeloid Leukemia

Yuandong Feng, MD, Yachun Jia, Ying Shen, MD, Hongli Chen, Yue Peng, Ru Zhang, MD, Yun Yang, MD, Jian-Li Wang, MD PhD, Ju Bai, PhD, Fang-Xia Wang, MD PhD, Yan Xu, Aili He, MD

Blood (2018) 132 (Supplement 1): 5253.

https://doi.org/10.1182/blood-2018-99-114549

Published: 2018

Journal Articles

Deregulated Expression of Long Non-Coding RNA AC092580.4 in Acute Myeloid Leukemia

Yachun Jia, Yuandong Feng, MD, Ying Shen, MD, Hongli Chen, Ru Zhang, MD, Yue Peng, Yun Yang, MD, Ju Bai, PhD, Jian-Li Wang, MD PhD, Baiyan Wang, MD PhD, Fang-Xia Wang, MD PhD, Aili He, MD

Blood (2018) 132 (Supplement 1): 5254.

https://doi.org/10.1182/blood-2018-99-114917

Published: 2018

Journal Articles

Efficacy and Adverse Reactions of Gemcitabine Combined with Cyclophosphamide, Vinblastine and Prednisone Hydrogenation Regiments in Relapse and/or Refractory Non-Hodgkin's Lymphoma

Baiyan Wang, MD PhD, Jie Liu, MD, Yin-Xia Chen, MD, Xing-Mei Cao, MD, Wan-Hong Zhao, MD PhD, Jian-Li Wang, MD PhD, Xiao-Rong Ma, MD PhD, Yun Yang, MD, Peng-Yu Zhang, MD PhD, Fang-Xia Wang, MD PhD, Liu-Fang Gu, MD PhD, Bo Lei, MD, Jin Wang, MD PhD, Ju Bai, PhD, Yi-Lin Zhang, MD, Yan Xu, Ai-Li He, MD PhD, Wang-Gang Zhang, MD PhD

Blood (2018) 132 (Supplement 1): 5393.

https://doi.org/10.1182/blood-2018-99-116600

Published: 2018

Journal Articles

Platelet (hem)ITAM Signaling Mediated Cancer-Associated Venous Thrombosis

Xia Wang, MD, Jingchang Wu, PhD, Haidi Gu, MD, Jun Qian, PhD, Changgeng Ruan, MD PhD, Yiming Zhao, PhD

Blood (2018) 132 (Supplement 1): 2509.

https://doi.org/10.1182/blood-2018-99-116220

Published: 2018

Journal Articles

High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial

Yu Wei, Xue-bin Ji, Ya-wen Wang, Jing-xia Wang, En-qin Yang, Zheng-cheng Wang, Yu-qi Sang, Zuo-mu Bi, Cui-ai Ren, Fang Zhou, Guo-qiang Liu, Jun Peng, Ming Hou

Blood (2016) 127 (3): 296–302.

https://doi.org/10.1182/blood-2015-07-659656

Published: 2016

Journal Articles

Association Between Down-Regulation of EZH2 and Abnormal Karyotype, Response to Hypomethylation Treatment, and Patient Survival in Myelodysplastic Syndromes

Yue Wei, Monica Cabrero, MD, Yu Jia, Hong Zheng, Hui Yang, MD, PhD, Zhihong Fang, Zach Bohannan, Rui Chen, PhD, Hui Wang, PhD, Simona Colla, Xia Wang, Guillermo Garcia-Manero, MD

Blood (2014) 124 (21): 3241.

https://doi.org/10.1182/blood.V124.21.3241.3241

Published: 2014

Journal Articles

Assessment Of EZH2 Expression In CD34+ Bone Marrow Progenitor Cells Of Patients Of Myelodysplastic Syndromes (MDS)

Yue Wei, PhD, Yu Jia, Hong Zheng, Hui Yang, MD, PhD., Rui Chen, Ph.D., Hui Wang, Ph.D., Xia Wang, Guillermo Garcia-Manero, MD

Blood (2013) 122 (21): 2805.

https://doi.org/10.1182/blood.V122.21.2805.2805

Published: 2013

Journal Articles

Ly6G ligation blocks recruitment of neutrophils via a β2-integrin–dependent mechanism

Jun-Xia Wang, Angela M. Bair, Sandra L. King, Ruslan Shnayder, Ya-Fang Huang, Chi-Chang Shieh, Roy J. Soberman, Robert C. Fuhlbrigge, Peter A. Nigrovic

Blood (2012) 120 (7): 1489–1498.

https://doi.org/10.1182/blood-2012-01-404046

Published: 2012

Includes: Supplemental data

NARROW

Delivery of α-Particles By a Human-Rat Chimeric CD82 Monoclonal Antibody Potently Inhibits the Proliferation of CD82-Expressing Acute Myeloid Leukemia Cells in a Murine Xenograft Model

Application of Comprehensive Nursing Program Based on Evidence-Based Concept in Patients with HIV-Related Lymphoma

Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China

Long-Term Follow-up of a Phase 1, First-in-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (BCMA), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Using Circ-ANAPC7 As a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia

Silencing Long Non-Coding RNA ST3GAL6-AS1 Inhibits Adhesion and Migration of Myeloma Cells in Vitro

Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

A 3-LncRNA Risk Scoring System for Prognosis of Adult Acute Myeloid Leukemia

Deregulated Expression of Long Non-Coding RNA AC092580.4 in Acute Myeloid Leukemia

Efficacy and Adverse Reactions of Gemcitabine Combined with Cyclophosphamide, Vinblastine and Prednisone Hydrogenation Regiments in Relapse and/or Refractory Non-Hodgkin's Lymphoma

Platelet (hem)ITAM Signaling Mediated Cancer-Associated Venous Thrombosis

High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial

Association Between Down-Regulation of EZH2 and Abnormal Karyotype, Response to Hypomethylation Treatment, and Patient Survival in Myelodysplastic Syndromes

Assessment Of EZH2 Expression In CD34+ Bone Marrow Progenitor Cells Of Patients Of Myelodysplastic Syndromes (MDS)

Ly6G ligation blocks recruitment of neutrophils via a β2-integrin–dependent mechanism

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only